Your browser doesn't support javascript.
loading
A quadruple blinded placebo controlled randomised trial to evaluate the effectiveness of an Iodine complex for patients with mild to moderate COVID-19 in Pakistan (I-COVID-PK): A structured summary of a study protocol for a randomised controlled trial.
Ashraf, Sohaib; Ashraf, Shoaib; Ashraf, Moneeb; Imran, Muhammad Ahmad; Kalsoom, Larab; Siddiqui, Uzma Nasim; Farooq, Iqra; Ghufran, Muhammad; Khokhar, Romaisa Arshad; Akram, Muhammad Kiwan; Shahid, Iqra; Sohaib Ur Rehman, Muhammad; Akmal, Rutaba; Tahir, Arbaz; Zahid, Ayesha; Ashraf, Sidra; Rafique, Sundas; Matti, Nazish; Nadeem, Muhammad Faisal; Humayun, Ayesha; Malik, Amber; Saboor, Qazi Abdul; Ahmad, Ali; Ashraf, Muhammad; Izhar, Mateen.
Afiliación
  • Ashraf S; Department of Cardiology, Shaikh Zayed Post-Graduate Medical Institute, Lahore, Pakistan. sohaib@skzmdc.edu.pk.
  • Ashraf S; Department of Pathobiology, Riphah International, Lahore, Pakistan. shoaib.ashraf@mail.mcgill.ca.
  • Ashraf M; Department of Pharmacology, Mayo Hospital, King Edward Medical University, Lahore, Pakistan.
  • Imran MA; Department of Microbiology, Shaikh Zayed Post-Graduate Medical Institute, Lahore, Pakistan.
  • Kalsoom L; Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.
  • Siddiqui UN; Department of Medicine, Shaikh Zayed Post-Graduate Medical Institute, Lahore, Pakistan.
  • Farooq I; Department of Medicine, Port Macquarie Base Hospital, New south Wales, Australia.
  • Ghufran M; Department of Paediatric Surgery, Children Hospital, Lahore, Pakistan.
  • Khokhar RA; ESACHS (Empresa de Servicios Externos de la Asociación Chilena de Seguridad), Santiago, Chile.
  • Akram MK; Department of Oral Pathology, Shifa College of dentistry, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
  • Shahid I; Department of animal nutrition, University of veterinary and animal sciences, Lahore, Pakistan.
  • Sohaib Ur Rehman M; Department of gynaecology and obstetrics, Benazir Bhutto Hospital, Rawalpindi, Pakistan.
  • Akmal R; Department of Public Health and Community Medicine, Shaikh Zayed Medical complex, Lahore, Pakistan.
  • Tahir A; Department of Community Medicine, Sahara Medical College, Narowal, Pakistan.
  • Zahid A; Department of Community Medicine, Faisalabad Medical University, Faisalabad, Pakistan.
  • Ashraf S; Department of Medicine, Services Institute of Medical Sciences, Lahore, Pakistan.
  • Rafique S; Department of biochemistry, University of veterinary and animal sciences, Lahore, Pakistan.
  • Matti N; Department of West Medicine, Mayo Hospital, King Edward Medical University, Lahore, Pakistan.
  • Nadeem MF; Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
  • Humayun A; Institute of Pharmaceutical Sciences, University of Veterinary and Animal Sciences, Lahore, Pakistan.
  • Malik A; Department of Public Health and Community Medicine, Shaikh Zayed Medical complex, Lahore, Pakistan.
  • Saboor QA; Department of Cardiology, Evercare Hospital, Lahore, Pakistan.
  • Ahmad A; Department of Cardiology, Shaikh Zayed Post-Graduate Medical Institute, Lahore, Pakistan. drsaboor04@gmail.com.
  • Ashraf M; Department of Microbiology, Infectiology and Immunology, Centre Hospitalier Universitaire (CHU) Sainte Justin/University of Montreal, Montreal, Canada. ali.ahmad@recherche-ste-justine.qc.ca.
  • Izhar M; Department of Pharmacology and Toxicology, University of veterinary and animal sciences, Lahore, Pakistan. drashraf2001@uvas.edu.pk.
Trials ; 22(1): 127, 2021 Feb 10.
Article en En | MEDLINE | ID: mdl-33568226

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / Índice de Severidad de la Enfermedad / Compuestos de Yodo / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Polímeros / Índice de Severidad de la Enfermedad / Compuestos de Yodo / SARS-CoV-2 / Tratamiento Farmacológico de COVID-19 Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: Pakistán Pais de publicación: Reino Unido